Abstract
CBL-514 has been shown to be effective and safe for reducing abdominal subcutaneous fat. Evidence from several trials indicates significant fat volume reduction with mild to moderate adverse effects confined to injection sites.
Keywords
- Body Contouring and Surgery
- subcutaneous fat loss
- lipolysis
- abdominal fat
- safety
- efficacy
- adverse effects
- injection site reactions
- Open access
Source
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.